ECM
IART icon

ETrade Capital Management’s Integra LifeSciences IART Stock Holding History

ETrade Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,510
Closed -$541K – 915
2020
Q2 		$541K Buy
11,510
+114
+1% +$5.6K 0.01% 519
2020
Q1 		$509K Buy
11,396
+1,172
+11% +$61.5K 0.01% 467
2019
Q4 		$596K Buy
10,224
+465
+5% +$27.7K 0.01% 512
2019
Q3 		$586K Buy
9,759
+1,349
+16% +$80.4K 0.01% 522
2019
Q2 		$470K Buy
+8,410
New +$433K 0.01% 580
2019
Q1 		– Sell
-5,569
Closed -$251K – 822
2018
Q4 		$251K Buy
5,569
+49
+0.9% +$2.69K 0.01% 669
2018
Q3 		$364K Buy
5,520
+150
+3% +$9.32K 0.01% 624
2018
Q2 		$346K Buy
5,370
+309
+6% +$19.1K 0.01% 610
2018
Q1 		$280K Sell
5,061
-10,850
-68% -$569K 0.01% 645
2017
Q4 		$762K Buy
15,911
+465
+3% +$22.8K 0.02% 403
2017
Q3 		$780K Buy
15,446
+505
+3% +$25.9K 0.03% 367
2017
Q2 		$814K Buy
14,941
+617
+4% +$29.5K 0.03% 342
2017
Q1 		$603K Buy
14,324
+3,670
+34% +$157K 0.02% 398
2016
Q4 		$457K Buy
10,654
+3,324
+45% +$135K 0.02% 413
2016
Q3 		$303K Buy
7,330
+1,470
+25% +$61.6K 0.01% 448
2016
Q2 		$234K Buy
+5,860
New +$211K 0.01% 443

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

ETrade Capital Management's IART Position: Q3 2020 in Review

ETrade Capital Management sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 11,510 shares — an estimated $541K sold.

ETrade Capital Management first reported a position in IART in Q2 2016 and held it in 16 quarters. The position peaked at $814K in Q2 2017. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

  • ETrade Capital Management reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
  • ETrade Capital Management sold 11,510 Integra LifeSciences shares in Q3 2020, an estimated $541K.
  • ETrade Capital Management first reported a position in Integra LifeSciences in Q2 2016 and held it in 16 quarters.
  • ETrade Capital Management's Integra LifeSciences position peaked at $814K in Q2 2017.
  • 237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.